Media ReleasesCyclopharm

View All Cyclopharm News

CYC First Half Trading Update

Cyclopharm Limited (ASX: CYC) is pleased to provide the following update on its trading performance for first half of 2021.

Following a review of the company’s unaudited management accounts for the six months ending 30 June 2021, Cyclopharm expects to report record half year revenues of approximately $8.1 million, exceeding the company’s pre-COVID financial performance.

For more information, download the attached PDF.

Download this document

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.